In this week’s REWIND of international business news, we discuss Moody’s rating of the U.S., scrutiny of pharmaceutical companies by Chinese regulators, and the approval of a merger of two U.S. companies by the European Commission.» Read More
The United States government has moved to vigorously enforce the Foreign Corrupt Practices Act over the past several years and this has profound implications for companies working overseas.
The Foreign Corrupt Practices Act, 15 U.S.C. Section 788dd-1(a) (the “Act” or “FCPA”) prohibits “corrupt” offers of any kind of payment to a foreign official when the payment is for obtaining or retaining business. » Read More